Cancer genesis: Stem tumour cells as an MHC-null/HSP70 - Very high 'primordial self' escaping both MHC-restricted and MHC-non-restricted immunesurveillance

Medical Hypotheses

Volumn 56, Issue 6, 2001, Pages 724-730

  Manzo, G ^a  

^a NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70;

ALLOGRAFT; ARTICLE; BONE MARROW CELL; CANCER IMMUNOTHERAPY; CARCINOGENESIS; EMBRYO CELL; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSURVEILLANCE; INTERFEROMETER; MAJOR HISTOCOMPATIBILITY COMPLEX; PHENOTYPE; PRIORITY JOURNAL; STEM CELL; TUMOR GROWTH;

EID: 0034960675     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.2000.1179     Document Type: Article

References (39)

1. Phylogenesis, ontogenesis, oncogenesis
2. Selective loss of HLA-A on HLA-B antigen expression in colon carcinoma
3. HLA class I gene expression on human primary tumors and autologous metastases: Demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas
4. Immunological correlations between ontogenesis and oncogenesis: Theoretical implications and suggestions for tumor immunotherapy
5. Altered protein synthesis in p53 null and hemizygous transgenic mouse embryonic fibroblasts
6. Cancer: A biological problem without any natural immunological solution? A unified theory with implications for grafts, pregnancy and tumor immuno-prophylaxis
7. Expression of HLA-AB,C antigens on primary and metastatic tumor cell populations of human carcinomas
8. The cancer process as a type of immunocomplex hypersensibility involving C3b, natural killer cytotoxicity and antibody-dependent cell cytotoxicity: Proposals for tumour immunotherapy and vaccine
9. Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen-antibody complexes
10. Natural killer cells mediate lysis of embryonal carcinoma cells lacking MHC
11. Role of NK cells in the control of metastatic spread of tumor cells in mice
12. Natural killer cell activity predicts metastases from poorly-differentiated head and neck cancer
13. Increase of serum complement levels in cancer patients with progressing tumors
14. Complement activation in vivo in cancer patients receiving C. parvum immunotherapy
15. Significato degli alti livelli di complemento nelle neoplasie. Atti congresso Soc. It
16. Heat shock protein-based cancer vaccines and related thoughts on immunogenicity of human tumors
17. Come le cellule reagiscono allo stress
18. Immunological evidence for the association of p53 with a heat shock protein, hsc 70, in p53-plus-ras-transformed cell lines
19. Unusual expression and localization of heat shock proteins in human tumor cells
20. 70 KDa heat shock cognate protein is a transformation associated antigen and a possile target for host's anti tumor immunity
21. Heat- or stress-inducible transformation-associated cell surface antigen on the activated H-ras oncogene-transfected rat fibroblast
22. A critical contemplation on the role of heat shock proteins in transfer of antigenic peptides during antigen presentation
23. Heat shock proteins transfer peptides during antigen processing and CTL priming
24. Tumor rejection antigen gp96/grp94 is an ATPase: Implications for protein folding and antigen presentation
25. Tumor-specific immunogenicity of stress induced proteins: Convergence of two evolutionary pathways of antigen presentation?
26. Stress proteins, infection, and immune surveillance
27. Heat shock proteins in immune response to cancer: The fourth paradigm
28. CD3-large granular lymphocytes recognize a heat-inducible immunogenic determinant associated with the 72-KDa heat shock protein on human sarcoma cells
29. The sensitivity of certain tumour target cells to natural killing increases after stressing (heating)
30. Interaction of the immunosuppressant deoxyspergualin with a member of the HSP70 family of heat shock proteins
31. Heat shock protein 70 associated peptides elicit specific cancer immunity
32. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70
33. Heat shock proteins HSP70, HSP90 and Gp96 elicit tumor specific immunity to the tumor from which they are isolated
34. Natural Killer 1994, enhancing factor is an oxidative stress protein
35. Stress-induced proteins in immune response to cancer
36. Identification of a peptide binding protein that plays a role in antigen presentation
37. A peptide binding protein having a role in antigen presentation is a member of the HSP70 heat shock family
38. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations
39. Study of Fab and F(ab) 2 from rabbit IgG for capacity to induce lymphocyte-mediated target cell destruction in vitro